AzTrials
AzTrials

Appetite RegulationS2RBAMNCT02011217

The Effects of Rye Crisp Bread on Appetite and Metabolic Function

A study testing Rye crisp bread A, Rye crisp bread B and Wheat crisp bread C in people with Appetite Regulation, run by Swedish University of Agricultural Sciences at 1 site in Sweden.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of this study is to contribute to a better understanding of how dietary fibre in rye affects appetite and metabolic processes. We will evaluate how the intake of rye crisp breads affects appetite, insulin secretion and glucose levels in the blood in healthy humans. Read more about this study

Who is it for?
Ages 18 to 70 yearsHealthy volunteers can take part
Conditions the study is for
Appetite Regulation
What is being tested?
Rye crisp bread A, Rye crisp bread B and Wheat crisp bread C
Could I receive a placebo?
No, everyone receives an active treatment
How many people
25 participants
Where
1 siteSweden
Study dates
Aug 2013to Sep 2013
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 70 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Habitual breakfast eaters

Who cannot join

  • Pregnancy, lactation or wishing to become pregnant during the study period
  • Dieting
  • Weightloss
  • Eating disorder
  • Hyperglycemic
  • Hyperinsulinemic
Show all 14Show fewer
  • Thyroid disease
  • Metabolic issues
  • Diabetes
  • Physical or psychological problems with eating
  • Food intolerance/allergies to foods included in the study
  • Intolerance/allergy to paracetamol
  • Heavy smokers
  • Recent or concurrent participation in a dietary intervention research study

Trial locations and contacts

1 site in 1 country.

Sweden1 site
  • Paediatric Research Facility; The Children's Hospital at Uppsala University Hospital

    Uppsala, Uppsala County, SE-751 85

Other trials in Sweden

About this study

Official title: The Effects of Rye Crisp Bread on Subjective Appetite and Metabolic Function After Short-term Consumption

The aim of this study is to contribute to a better understanding of how dietary fibre in rye affects appetite and metabolic processes. We will evaluate how the intake of rye crisp breads affects appetite, insulin secretion and glucose levels in the blood in healthy humans. We will also investigate microstructural properties of the crisp breads with microscopy, as well as to characterize the food products with respect to the content of dietary fibre and certain bioactive compounds. The aim is also to try to elucidate how observed effects on appetite are related to changes in insulin and glucose levels, appetite related hormonal signals and microstructural properties to verify findings from previous studies.

Read the detailed description

The short-term effects (up to 4 hours after intake) of rye crisp breads on subjective appetite and metabolism will be evaluated using a randomized cross-over study design. Each participant will consume three different breakfasts consisting of two different rye crisp breads and one wheat crisp bread on three different occasions separated by a 1 week wash-out period. Participants will rate subjective appetite (satiety, hunger and desire to eat) by using a visual analogue scale (VAS) every 30 min during a 4-hour period, starting 30 min before breakfast. Blood samples will be collected before breakfast and at regular intervals throughout the day for analysis of glucose, insulin and hormone levels. Gastric emptying rate will also be evaluated using paracetamol as an indicator. Glucose and hormonal responses will be related to subjective appetite and to differences in composition of the breakfasts.

Being tested
Rye crisp bread A, Rye crisp bread B, Wheat crisp bread C
Keywords
Rye, Dietary Fibre, Bread, Crisp bread, Appetite, Satiety, Hunger, Desire to eat, Metabolism, Glucose, Insulin, Gut hormones, Gastric emptying rate
Medical subject headings
Insulin Resistance

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Rye crisp bread AOther

    In a randomized cross-over design each subject receive one of three iso-caloric breakfasts on three different occasions, separated by 1 week wash-out period.

  • Rye crisp bread BOther

    In a randomized cross-over design each subject receive one of three iso-caloric breakfasts on three different occasions, separated by 1 week wash-out period.

  • Wheat crisp bread COther

    In a randomized cross-over design each subject receive one of three iso-caloric breakfasts on three different occasions, separated by 1 week wash-out period.

Study groups in NCT02011217
Study groupRoleWhat they receive
Rye crisp bread AExperimentalNot described
Receives: Other: Rye crisp bread B; Other: Wheat crisp bread C
Rye crisp bread BExperimentalNot described
Receives: Other: Rye crisp bread A; Other: Wheat crisp bread C
Wheat crisp bread CExperimentalNot described
Receives: Other: Rye crisp bread A; Other: Rye crisp bread B

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Subjective Appetite Profiles during 4 hours

    Subjective feelings of appetite (satiety, hunger and desire to eat) assessed by visual analogue scale (VAS).

    Measured: -30, 0, 30, 60, 90, 120, 150, 180, 210, 240 minutes

Secondary outcomes (3)
  1. Gastric Emptying Rate during 4 hours

    Paracetamol (1 g) taken with breakfast. The appearance of paracetamol in the blood is directly related to the rate of gastric emptying.

    Measured: -15, 15, 35, 65, 95, 125, 185, 230 minutes

  2. Hormonal Responses during 4 hours

    Glucagon, glucagon-like peptide-1 (GLP-1), glucose-dependent insulino-tropic polypeptide (GIP), peptide YY (PYY), cholecystokinin (CCK), leptin and ghrelin are measured in plasma samples.

    Measured: -15, 15, 35, 65, 95, 125, 185, 230 minutes

  3. Glucose and Insulin Responses during 4 hours

    Glucose and insulin are measured in plasma samples.

    Measured: -15, 15, 35, 65, 95, 125, 185, 230 minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Dec 2013 (estimated)
  2. Study startAug 2013
  3. Primary completionSep 2013
  4. Study completionSep 2013

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Crossover
Masking
Single blind
Who is masked
Participant
Enrolment
25 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02011217
Sponsor's protocol ID
SLU-IL-S2
Acronym
S2RBAM
Status last verified
Dec 2013
First submitted
6 Nov 2013
Last updated
13 Dec 2013
Results posted
No
Data monitoring committee
No

Publications

  • Johansson DP, Lee I, Riserus U, Langton M, Landberg R. Effects of unfermented and fermented whole grain rye crisp breads served as part of a standardized breakfast, on appetite and postprandial glucose and insulin responses: a randomized cross-over trial. PLoS One. 2015 Mar 31;10(3):e0122241. doi: 10.1371/journal.pone.0122241. eCollection 2015.

    PubMed 25826373

Questions about this trial

What is this clinical trial studying?

A study testing Rye crisp bread A, Rye crisp bread B and Wheat crisp bread C in people with Appetite Regulation, run by Swedish University of Agricultural Sciences at 1 site in Sweden.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 14 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 13 Dec 2013. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Subjective Appetite Profiles during 4 hours (time frame: -30, 0, 30, 60, 90, 120, 150, 180, 210, 240 minutes). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02011217, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Dec 2013.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in